The NUP98-HOXD13 transgenic model (NHD13) recapitulates many of the salient features of MDS, including neutropenia, lymphopenia and hypercellular or normocellular bone marrow at 4–7 months13, 14, 15, 16. This evidence concerns the gene HOXD13 and myelodysplastic syndrome.